Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Drug Design

"Drug Design" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include pharmacokinetics, dosage analysis, or drug administration analysis.


This graph shows the total number of publications written about "Drug Design" by people in Harvard Catalyst Profiles by year, and whether "Drug Design" was a major or minor topic of these publication.
Bar chart showing 834 publications over 31 distinct years, with a maximum of 58 publications in 2015
To see the data from this visualization as text, click here.
Related Networks
People
Explore
_
Similar Concepts
_
Top Journals 
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.